Alternative to Gait Speed in Sarcopenia Assessment

NCT ID: NCT07065448

Last Updated: 2025-07-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

96 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-04-01

Study Completion Date

2025-07-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to assess the reliability of the Elbow Performance Test as an upper extremity-based alternative for evaluating sarcopenia severity. Unlike traditional lower extremity-focused assessments, this test may offer a practical solution for individuals with mobility limitations or comorbidities affecting the lower limbs. Participants will include older adults with sarcopenia and healthy young adults. Functional tests, including the 4-meter Gait Speed Test, SPPB, TUG, and the Elbow Performance Test, will be administered twice within a 7-10-day interval. Reliability will be analyzed using intraclass correlation coefficients (ICC).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background:Sarcopenia is a generalized and progressive skeletal muscle disorder characterized by a decline in muscle strength, mass, and function. The severity of sarcopenia is commonly assessed using functional performance tests, which are also used for monitoring disease progression and treatment response. However, lower extremity-based tests may have limited applicability in the presence of various comorbidities.

Objective: This study proposes an upper extremity-based alternative, the Elbow Performance Test, and aims to evaluate its reliability in comparison to the commonly used 4-meter Gait Speed Test.

Method:This planned cross-sectional study will include two groups: older adults with sarcopenia and healthy young adults. All participants will undergo the 4-meter Gait Speed Test, the Short Physical Performance Battery (SPPB), the Timed Up and Go (TUG) test, and the Elbow Performance Test on two separate occasions, with a 7-10-day interval between sessions. In the Elbow Performance Test, a 1-kilogram sandbag will be attached to the distal forearm of the dominant arm, and participants will be instructed to perform 30 consecutive elbow flexion-extension movements. The total time required to complete the repetitions will be recorded. The reliability of the test will be evaluated using intraclass correlation coefficients (ICC).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sarcopenia Elderly

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1

older adults with sarcopenia

physical performance tests

Intervention Type OTHER

All participants underwent the 4-meter Gait Speed Test, the Short Physical Performance Battery (SPPB), the Timed Up and Go (TUG) test, and the Elbow Performance Test twice, with a 7-10-day interval between sessions. In the Elbow Performance Test, a 1-kilogram sandbag was fixed to the distal forearm of the dominant arm, and participants were asked to perform 30 consecutive elbow flexion-extension movements.

Group 2

healthy young adults

physical performance tests

Intervention Type OTHER

All participants underwent the 4-meter Gait Speed Test, the Short Physical Performance Battery (SPPB), the Timed Up and Go (TUG) test, and the Elbow Performance Test twice, with a 7-10-day interval between sessions. In the Elbow Performance Test, a 1-kilogram sandbag was fixed to the distal forearm of the dominant arm, and participants were asked to perform 30 consecutive elbow flexion-extension movements.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

physical performance tests

All participants underwent the 4-meter Gait Speed Test, the Short Physical Performance Battery (SPPB), the Timed Up and Go (TUG) test, and the Elbow Performance Test twice, with a 7-10-day interval between sessions. In the Elbow Performance Test, a 1-kilogram sandbag was fixed to the distal forearm of the dominant arm, and participants were asked to perform 30 consecutive elbow flexion-extension movements.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Individuals who consent to participate in the study

\*Sarcopenia Group
* Male participants aged 60 years or older
* Diagnosed with sarcopenia according to EWGSOP2 criteria

\*Healthy Young Control Group
* Male participants aged 40 years or younger
* SARC-F screening test score \< 4

Exclusion Criteria

* Inability to cooperate
* Poor general condition due to acute medical problems
* Chronic decompensated cardiac, renal, or hepatic failure
* Presence of rheumatologic, psychiatric, or neurological disorders
* Use of performance-enhancing or fatigue-reducing medications
Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Istanbul Physical Medicine Rehabilitation Training and Research Hospital

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Eser Kalaoglu

M.D.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

İlhan Karacan, Prof.

Role: STUDY_DIRECTOR

Istanbul Physical Medicine Rehabilitation Training and Research Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Istanbul Physical Medicine Rehabilitation Training and Research Hospital

Istanbul, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

References

Explore related publications, articles, or registry entries linked to this study.

Bahat G, Tufan A, Tufan F, Kilic C, Akpinar TS, Kose M, Erten N, Karan MA, Cruz-Jentoft AJ. Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition. Clin Nutr. 2016 Dec;35(6):1557-1563. doi: 10.1016/j.clnu.2016.02.002. Epub 2016 Feb 11.

Reference Type BACKGROUND
PMID: 26922142 (View on PubMed)

Power GA, Dalton BH, Rice CL. Human neuromuscular structure and function in old age: A brief review. J Sport Health Sci. 2013 Dec;2(4):215-226. doi: 10.1016/j.jshs.2013.07.001.

Reference Type BACKGROUND
PMID: 27011872 (View on PubMed)

Karacan I, Turker KS. Exploring neuronal mechanisms of osteosarcopenia in older adults. J Physiol. 2024 Aug 9. doi: 10.1113/JP285666. Online ahead of print.

Reference Type BACKGROUND
PMID: 39119811 (View on PubMed)

Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019 Jan 1;48(1):16-31. doi: 10.1093/ageing/afy169.

Reference Type BACKGROUND
PMID: 30312372 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IstPRMTRH-TYY1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Ankle Assistance and Resistance in Older Adults
NCT06284525 COMPLETED EARLY_PHASE1
Neuroathletic Exercise In The Elderly
NCT07070336 RECRUITING NA